New research suggests that dosage plays a role in a rare side effect of A.D.H.D. stimulants.
https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png00https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png2024-09-12 15:46:172024-09-12 15:46:17Adderall, Vyvanse in Higher Doses May Be Tied to Psychosis Risk, Study Says
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.